Endocyte, Inc. Common Stock
ECYT
ECYT was delisted on the 20th of December, 2018.
98 hedge funds and large institutions have $109M invested in Endocyte, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 14 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 28
3% more capital invested
Capital invested by funds: $106M → $109M (+$2.7M)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
2% less funds holding
Funds holding: 100 → 98 (-2)
25% less call options, than puts
Call options by funds: $1.49M | Put options by funds: $1.98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$5M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.32M |
| 3 |
State Street
Boston,
Massachusetts
|
+$885K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$322K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$272K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.5M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$921K |
| 3 |
Renaissance Technologies
New York
|
-$914K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$774K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$494K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Group One Trading
Chicago,
Illinois
| – | -$203K | -35,138 | Closed |
|
|
RJA
102
Raymond James & Associates
St Petersburg,
Florida
| – | -$213K | -33,791 | Closed |
|
103
Axa
Paris,
France
| – | -$177K | -28,100 | Closed |
|
|
DTL
104
Dynamic Technology Lab
Singapore
| – | -$151K | -24,032 | Closed |
|
105
SG Americas Securities
New York
| – | -$144K | -22,826 | Closed |
|
|
NPF
106
Norris Perne & French
Grand Rapids,
Michigan
| – | -$68K | -10,842 | Closed |
|
|
SCM
107
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$67K | -10,695 | Closed |
|
|
VKH
108
Virtu KCG Holdings
New York
| – | -$66K | -10,502 | Closed |
|
|
QT
109
Quantbot Technologies
New York
| – | -$25K | -4,101 | Closed |
|
|
BRWA
110
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$9 | -1,500 | Closed |
|
|
TRCT
111
Tower Research Capital (TRC)
New York
| – | -$7K | -1,155 | Closed |
|
112
Envestnet Asset Management
Chicago,
Illinois
| – | -$5K | -789 | Closed |
|
ECYT Hedge Fund Activity: Q1 2015 in Review
98 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q1 2015, worth a combined $109M — up 2.5% from $106M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ECYT and 13 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 34 added.
The largest buyer was Highland Capital Management (Texas), adding an estimated $5M. The largest seller was Numeric Investors, cutting an estimated $1.5M.
- 98 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q1 2015, down from 100 in Q4 2014.
- Funds reported $109M of Endocyte, Inc. Common Stock stock for Q1 2015, up 2.5% quarter-over-quarter.
- 13 funds opened new Endocyte, Inc. Common Stock positions in Q1 2015 and 14 closed out, a net change of -1 holder.
- The largest Endocyte, Inc. Common Stock buyer in Q1 2015 was Highland Capital Management (Texas), an estimated $5M added.
- The largest Endocyte, Inc. Common Stock seller in Q1 2015 was Numeric Investors, an estimated $1.5M sold.
Based on aggregated 13F filings for Q1 2015.